Barclays raised the firm’s price target on Aptiv (APTV) to $80 from $75 and keeps an Overweight rating on the shares. The company reported a Q4 beat and a 2025 guidance ahead of expectations, the analyst tells investors in a research note. The firm says this marks the first positive revisions for Aptiv in 15 months.